- HK$7.05bn
- HK$138.26bn
- CNY107.96bn
- 23
- 89
- 20
- 37
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | CAS | CAS | CAS | CAS | CAS |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 91,829 | 108,005 | 123,634 | 102,822 | 107,956 |
Cost of Revenue | |||||
Gross Profit | 21,961 | 20,184 | 18,582 | 14,396 | 10,152 |
Selling / General / Administrative Expenses | |||||
Research And Development | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 83,884 | 100,578 | 116,475 | 99,693 | 107,799 |
Operating Profit | 7,945 | 7,427 | 7,159 | 3,129 | 156 |
Gain / Loss on Sale of Assets | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | 7,934 | 7,794 | 7,881 | 3,325 | 300 |
Provision for Income Taxes | |||||
Net Income After Taxes | 5,178 | 5,156 | 5,213 | 1,740 | -1,287 |
Minority Interest | |||||
Net Income Before Extraordinary Items | |||||
Net Income | 3,694 | 2,844 | 2,933 | 1,213 | 25.3 |
Adjustments to Net Income | |||||
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Dilution Adjustment | |||||
Diluted Net Income | 3,694 | 1,997 | 2,165 | 350 | -857 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 0.385 | 0.198 | 0.172 | -0.022 | -0.141 |
Dividends per Share |